newsfilter
← Latest News
Business Wire·

Successful Patient Outcomes Demonstrated With Edwards' SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025

EW

ENCIRCLE mitral trial achieves primary and secondary endpoints EVOQUE tricuspid valve registry demonstrates more favorable outcomes than pivotal trial Edwards Lifesciences (NYSE:EW) today announced data demonstrating